UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000033259 |
|---|---|
| Receipt number | R000037915 |
| Scientific Title | The study of gut microbiota modulation by elobixibat in chronic constipation |
| Date of disclosure of the study information | 2018/07/09 |
| Last modified on | 2020/04/12 15:23:06 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The study of gut microbiota modulation by elobixibat in chronic constipation
Acronym
The study of gut microbiota modulation by elobixibat in chronic constipation
Scientific Title
The study of gut microbiota modulation by elobixibat in chronic constipation
Scientific Title:Acronym
The study of gut microbiota modulation by elobixibat in chronic constipation
Region
| Japan |
Condition
Condition
Chronic constipation
Classification by specialty
| Gastroenterology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To assess gut microbiota modulation by increase of bile acid in the colon
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Gut microbiota modulation from baseline to 2 weeks
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 80 | years-old | > |
Gender
Male and Female
Key inclusion criteria
(1) Patients who are diagnosed chronic constipation by ROME criteria
(2) Patients who can exhibit their consent in a document
Key exclusion criteria
(1) Patients who have severe complications
(2) Patients who were administered elobixibat or antibiotics within 1 month
(3) Patients who have history of elobixibat allergies
(4) Patients who have bristol score 7
(5) Patients who have severe psychiatric disease
(6) Patients who have current evidence of abuse of drugs or alcohol
(7) Patients who or are going to take new medicines
(8) Patients who or are going to be participating in other clinical studies
(9) Patients who are judged as inadequately for study entry
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Noboru Misawa |
Organization
Yokohama City University school of medicine
Division name
Department of gastroenterology and hepatology
Zip code
Address
3-9 Fukuura Kanazawa-ku Yokohama City
TEL
045-787-2640
misawa-ykh@umin.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Noboru Misawa |
Organization
Yokohama City University school of medicine
Division name
Department of gastroenterology and hepatology
Zip code
Address
3-9 Fukuura Kanazawa-ku Yokohama City
TEL
045-787-2640
Homepage URL
misawa-ykh@umin.ac.jp
Sponsor or person
Institute
Yokohama City University School of Medicine Department of Gastroenterology and Hepatology
Institute
Department
Personal name
Funding Source
Organization
Yokohama City University School of Medicine Department of Gastroenterology and Hepatology
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2018 | Year | 07 | Month | 09 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2018 | Year | 06 | Month | 28 | Day |
Date of IRB
Anticipated trial start date
| 2018 | Year | 07 | Month | 15 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
None
Management information
Registered date
| 2018 | Year | 07 | Month | 03 | Day |
Last modified on
| 2020 | Year | 04 | Month | 12 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037915
